These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9612780)

  • 1. [Multiple organ failure syndrome after ovarian hyperstimulation].
    Diatta B; Petrognani R; Angel G; Marquine C; Eliet J; Seck M; Seignot P
    Med Trop (Mars); 1997; 57(4):373-4. PubMed ID: 9612780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer associated with ovulation induction: a case report.
    Adewole IF; Babarinsa IA; Thomas JO; Ajayi AB
    Afr J Med Med Sci; 1997; 26(3-4):203-4. PubMed ID: 10456173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive toxicity of ovulation induction.
    Tucker KE
    Semin Reprod Endocrinol; 1996 Nov; 14(4):345-53. PubMed ID: 8988529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian hyperstimulation syndrome associated with clomiphene citrate.
    Mitchell SY; Fletcher HM; Williams E
    West Indian Med J; 2001 Sep; 50(3):227-9. PubMed ID: 11769032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Update on ovarian hyperstimulation syndrome].
    Delbaere A; Rodesch C; Englert Y
    Rev Med Brux; 1995 Nov; 16(5):354-60. PubMed ID: 7501911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple cerebral infarctions associated with ovarian hyperstimulation syndrome.
    Yoshii F; Ooki N; Shinohara Y; Uehara K; Mochimaru F
    Neurology; 1999 Jul; 53(1):225-7. PubMed ID: 10408568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
    Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ovarian hyperstimulation with menotropins as treatment for unexplained sterility; effect of reproductive characteristics on the results].
    Kably A; Reyes-Cuervo H; Barrón-Vallejo J
    Ginecol Obstet Mex; 1996 Sep; 64():402-5. PubMed ID: 8964541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian clear cell carcinoma occurring in a young patient with endometriosis and long-term ovulation stimulations.
    Saylam K; Devreker F; Simon P; Fayt I; Noël JC
    Acta Obstet Gynecol Scand; 2006; 85(12):1506-7. PubMed ID: 17260230
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
    Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
    West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ovarian hyperstimulation syndrome].
    Marques L; Stuck M; Gigon U; Pirovino M
    Schweiz Med Wochenschr; 1991 May; 121(21):777-82. PubMed ID: 1905421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial infarction complicating the initial phase of an ovarian stimulation protocol.
    Coli S; Magnoni M; Melisurgo G; Persico P; Doldi N; De Cobelli F; Del Maschio A; Cianflone D; Maseri A
    Int J Cardiol; 2007 Jan; 115(1):e56-7. PubMed ID: 17067704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver dysfunction in severe ovarian hyperstimulation syndrome.
    Obrzut B; Kuczyński W; Grygoruk C; Putowski L; Kluz S; Skret A
    Gynecol Endocrinol; 2005 Jul; 21(1):45-9. PubMed ID: 16048801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unilateral vulvar edema associated with paracentesis in patients with severe ovarian hyperstimulation syndrome. A report of nine cases.
    Luxman D; Cohen JR; Gordon D; Wolman I; Wolf Y; David MP
    J Reprod Med; 1996 Oct; 41(10):771-4. PubMed ID: 8913981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stimulation of ovulation and ovarian carcinoma. Literature Review].
    Trifonov I; Todorova M; Uzunova Zh
    Akush Ginekol (Sofiia); 2000; 40(4):39-41. PubMed ID: 11288633
    [No Abstract]   [Full Text] [Related]  

  • 16. [The ovarian hyperstimulation syndrome. Anesthesiologic aspects based on a severe case].
    Heylen I; Pichlmayr I; Schlösser HW
    Anaesthesist; 1990 Jun; 39(6):330-2. PubMed ID: 2375489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adnexal torsion in a woman undergoing ovarian hyperstimulation with clomiphene citrate therapy: a case report and review of the literature.
    Shiau CS; Huang YH; Chang MY; Lo LM; Hsieh TT; Hsieh CL
    Arch Gynecol Obstet; 2012 Jan; 285(1):271-3. PubMed ID: 21894563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to the treatment of ascites associated with ovarian hyperstimulation syndrome.
    Al-Ramahi M; Leader A; Claman P; Spence J
    Hum Reprod; 1997 Dec; 12(12):2614-6. PubMed ID: 9455823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Integral treatment of severe ovarian hyperstimulation syndrome by means of autotransfusion of ascitic fluid and intravenous infusion of albumin].
    Barrón Vallejo J; Pereyra Quiñones R; Esparza Iturbide JA; Kably Ambe A
    Ginecol Obstet Mex; 1998 Aug; 66():347-9. PubMed ID: 9745198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Severe ovarian hyperstimulation syndrome treatment by decompressive paracentesis and self-transfusion of ascitis fluid].
    Kably Ambe A; Ruiz Anguas J; Sánchez de León A
    Ginecol Obstet Mex; 2006 Jun; 74(6):291-9. PubMed ID: 16970114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.